Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Kevin Bielamowicz

Concepts (131)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Medulloblastoma
4
2022
16
1.240
Why?
Brain Neoplasms
10
2024
286
1.190
Why?
Glioblastoma
6
2018
91
1.160
Why?
T-Lymphocytes
7
2023
338
1.010
Why?
RNA-Binding Protein EWS
1
2024
14
0.950
Why?
Histiocytosis, Langerhans-Cell
1
2024
26
0.930
Why?
Interleukin-13 Receptor alpha2 Subunit
3
2018
4
0.930
Why?
Neoplasms, Germ Cell and Embryonal
1
2024
35
0.920
Why?
Central Nervous System Neoplasms
1
2024
63
0.900
Why?
Craniospinal Irradiation
2
2021
9
0.860
Why?
Receptors, Antigen, T-Cell
4
2018
50
0.830
Why?
Hypothyroidism
2
2021
54
0.810
Why?
Receptor, erbB-2
3
2018
73
0.780
Why?
Neoplasm Recurrence, Local
3
2024
618
0.770
Why?
Protons
2
2021
69
0.670
Why?
Antigenic Variation
2
2018
3
0.670
Why?
Receptor, EphA2
1
2018
5
0.630
Why?
Cerebellar Neoplasms
3
2022
22
0.460
Why?
Neuroblastoma
2
2024
52
0.440
Why?
Cancer Vaccines
3
2021
78
0.390
Why?
Testicular Hydrocele
1
2010
4
0.370
Why?
Genital Diseases, Female
1
2010
17
0.370
Why?
Thrombocytopenia
1
2011
84
0.370
Why?
Hernia, Inguinal
1
2010
19
0.360
Why?
Vagina
1
2010
45
0.360
Why?
Child
13
2024
6824
0.330
Why?
Immunotherapy
4
2024
238
0.320
Why?
Neoplasms
3
2023
1233
0.320
Why?
Humans
23
2024
49827
0.290
Why?
Immunotherapy, Adoptive
3
2023
154
0.240
Why?
Rhabdoid Tumor
1
2024
11
0.240
Why?
Child, Preschool
6
2024
3853
0.240
Why?
Neoplastic Syndromes, Hereditary
1
2024
16
0.240
Why?
Xenograft Model Antitumor Assays
3
2020
210
0.230
Why?
Gene Rearrangement
1
2024
74
0.230
Why?
Tumor Cells, Cultured
3
2020
465
0.220
Why?
Glioma
1
2024
79
0.220
Why?
Bacterial Infections
1
2023
98
0.220
Why?
Bacteremia
1
2023
92
0.210
Why?
Rhabdomyosarcoma, Alveolar
1
2022
8
0.210
Why?
Sarcoma, Ewing
1
2022
27
0.210
Why?
Proton Therapy
1
2021
9
0.200
Why?
Male
9
2024
25093
0.200
Why?
Adrenal Insufficiency
1
2021
18
0.200
Why?
Hematologic Neoplasms
1
2023
99
0.190
Why?
Leukemia
1
2021
65
0.190
Why?
DNA-Binding Proteins
1
2024
436
0.190
Why?
Female
10
2024
26329
0.190
Why?
Sepsis
1
2023
220
0.190
Why?
Mice, SCID
2
2018
175
0.180
Why?
Hypothalamic Diseases
1
2020
1
0.180
Why?
Ependymoma
1
2020
7
0.180
Why?
Cerebrospinal Fluid
1
2020
32
0.180
Why?
Methylphenidate
1
2020
74
0.170
Why?
Infant
3
2024
3551
0.170
Why?
Weight Loss
1
2020
239
0.160
Why?
Mice, Inbred NOD
1
2018
96
0.150
Why?
Antineoplastic Agents
2
2024
1172
0.150
Why?
Central Nervous System Stimulants
1
2020
213
0.150
Why?
Cell Proliferation
2
2018
1007
0.140
Why?
Receptors, Cell Surface
1
2017
121
0.140
Why?
Tumor Escape
1
2016
16
0.140
Why?
Mice
4
2020
5720
0.130
Why?
Apoptosis
2
2018
1100
0.130
Why?
Neoplasm Proteins
1
2017
323
0.130
Why?
Adolescent
3
2024
6340
0.120
Why?
Cell Nucleus
1
2014
184
0.110
Why?
Retrospective Studies
3
2021
6117
0.110
Why?
Up-Regulation
1
2014
450
0.100
Why?
Tumor Microenvironment
2
2024
210
0.100
Why?
Plasma Cell Granuloma, Pulmonary
1
2011
1
0.100
Why?
Septo-Optic Dysplasia
1
2011
2
0.100
Why?
Moyamoya Disease
1
2011
7
0.100
Why?
Slipped Capital Femoral Epiphyses
1
2011
8
0.100
Why?
Lung Neoplasms
1
2017
605
0.100
Why?
Obesity
1
2020
1113
0.100
Why?
Medical History Taking
1
2011
47
0.100
Why?
Diagnosis, Differential
2
2011
1036
0.090
Why?
Animals
4
2020
13150
0.090
Why?
Antigens, Neoplasm
2
2021
151
0.080
Why?
Ultrasonography
1
2010
436
0.080
Why?
Prognosis
3
2020
1952
0.080
Why?
MutS Homolog 2 Protein
1
2024
12
0.060
Why?
DNA Mismatch Repair
1
2024
17
0.060
Why?
CTLA-4 Antigen
1
2024
25
0.060
Why?
Follow-Up Studies
2
2020
2179
0.060
Why?
Survival Rate
2
2017
905
0.060
Why?
Fever
1
2023
117
0.050
Why?
Maximum Tolerated Dose
1
2022
37
0.050
Why?
Longitudinal Studies
1
2024
673
0.050
Why?
Adult
3
2024
13160
0.050
Why?
Growth Hormone
1
2021
96
0.050
Why?
Colorectal Neoplasms
1
2024
234
0.050
Why?
Incidence
1
2024
1003
0.050
Why?
Antibodies, Monoclonal, Humanized
1
2022
222
0.050
Why?
Radiotherapy Dosage
1
2021
243
0.050
Why?
Injections, Intraventricular
1
2020
13
0.050
Why?
HEK293 Cells
1
2020
222
0.040
Why?
Neoplasm Metastasis
1
2020
231
0.040
Why?
Cross-Sectional Studies
1
2024
1541
0.040
Why?
Drug Delivery Systems
1
2020
136
0.040
Why?
Treatment Outcome
2
2020
5138
0.040
Why?
Mutation
1
2024
1293
0.040
Why?
Anti-Bacterial Agents
1
2023
743
0.040
Why?
Microfilament Proteins
1
2017
43
0.040
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2024
987
0.040
Why?
Prospective Studies
1
2023
2344
0.040
Why?
Cytomegalovirus
1
2017
26
0.040
Why?
Adenoviridae
1
2017
51
0.040
Why?
Herpesvirus 4, Human
1
2017
35
0.040
Why?
Interleukin-13
1
2016
15
0.040
Why?
Neoplasm Transplantation
1
2016
85
0.030
Why?
Transgenes
1
2016
55
0.030
Why?
Protein Multimerization
1
2016
49
0.030
Why?
Lymphocyte Activation
1
2016
172
0.030
Why?
Young Adult
1
2024
3936
0.030
Why?
Protein Binding
1
2016
660
0.030
Why?
Case-Control Studies
1
2017
1128
0.030
Why?
Adoptive Transfer
1
2014
39
0.030
Why?
Cell Cycle
1
2014
232
0.030
Why?
Recurrence
1
2014
651
0.030
Why?
Cell Line, Tumor
1
2016
1402
0.030
Why?
Groin
1
2011
16
0.020
Why?
Cough
1
2011
54
0.020
Why?
Hypoglycemia
1
2011
48
0.020
Why?
Penis
1
2011
79
0.020
Why?
Anemia, Sickle Cell
1
2011
96
0.020
Why?
Radiography
1
2011
489
0.020
Why?
Pain
1
2011
380
0.020
Why?
Aged
1
2017
9272
0.010
Why?
Middle Aged
1
2017
11997
0.010
Why?
Bielamowicz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description